Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban vs Warfarin for Left Ventricular Thrombus
NCT02982590Phase 3Completed
- Sponsor
- Universiti Sains Malaysia
- Start
- Nov 2016
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of apixaban in Left ventricular thrombosis (LVT) (2 arms), sponsored by Universiti Sains Malaysia. Primary endpoint: Percent Change in Left Ventricular Thrombus (LVT) Size at 3 months. Started Nov 2016; status: completed.
02
Drugs
apixaban
03
Conditions
Left ventricular thrombosis (LVT)
Beyond the preview
Go deeper on NCT02982590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02982590.